deucravacitinib,apremilast
bms,amgen
['psoriasis', 'bms', 'bmsnews', 'bristol']
#media: today at #eadvcongress, we announced new long-term data showing durable efficacy for up to 2 years with a continuous treatment in plaque #psoriasis. 
Global Specialty Care BioPharma